Zhou, Mengting
Fan, Jun
Li, Zhenyu
Li, Pindong
Sun, Yajie
Yang, Yuhui
Zhou, Xiaoshu
Wang, Jing
Wang, Ye
Qi, Huiwei
Cai, Weijing
Dai, Xiaofang
Hirsch, Fred R.
Funding for this research was provided by:
National Natural Science Foundation of China (No. 81703847)
Article History
Received: 29 August 2019
Accepted: 2 October 2019
First Online: 7 November 2019
Ethics approval and consent to participate
: This Study was approved by Ethics Committee of Wuhan Union Hospital. All patients signed informed consent forms before the initiation of any study-related procedure.
: Not applicable.
: Fred R. Hirsch has participated in scientific advisory boards for: AstraZeneca, Genentech/Roche, Merck, Abbvie, Ventana Novartis, BMS, Pfizer, HTG Molecular and Biocept. FRH has received research funding (through University of Colorado) from: Amgen, Merck, Biodesix, Mersana, HTG Molecular, Rain Therapeutics., Abbvie.Huiwei Qi and Weijing Cai are the employees of Shanghai Tongshu Biotechnology Co., Ltd.All other authors declare no potential conflict of interest.